Gus, in late 2003 the market capitalisation was approximately $40mill, the market cap. today is around $125mill. They have 3x as many shares listed today as back then. Is the company really worth 3x more than back then based on their latest rejection by the FDA and revenue which is picking up very slowly plus their huge research costs and overheads?
Gus, in late 2003 the market capitalisation was approximately...
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
